Merck & Co., Inc. NYSE: $MRK April 17, 2015 LONG av $56.88
Merck & Co., Inc. (NYSE: MRK) April 17, 2015 LONG av $56.88
Merck & Co., Inc. is a global health care company. The company delivers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, which it markets directly and through its joint ventures. The Pharmaceutical segment includes the Company’s pharmaceutical products for health and human vaccines marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human diseases. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and health care providers managed. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines. Animal Health The Company’s products are sold to veterinarians, distributors and producers of animals.